Perchtoldsdorf, Austria

Michael Buschle

USPTO Granted Patents = 12 



Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 149(Granted Patents)


Location History:

  • Brunn am Gebirge, AT (1999)
  • Brunn/Gebirge, AT (2005 - 2006)
  • La Chaux-de-Fonds, CH (2012)
  • Perchtoldsdorf, AT (2006 - 2014)

Company Filing History:


Years Active: 1999-2014

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Mind of Michael Buschle

Introduction

Michael Buschle, a prominent inventor based in Perchtoldsdorf, Austria, has made significant contributions to the field of vaccine development. With a total of 12 patents to his name, Buschle's research focuses on enhancing immune responses through innovative vaccine compositions.

Latest Patents

Among his latest inventions is a vaccine composition that combines an antigen and a peptide with adjuvant properties. This innovation involves a peptide characterized by the sequence R—XZXZXZX—R, where N ranges from 3 to 7, with a preference for 5, and X represents a positively charged amino acid residue. The peptide's design aims to enhance a patient's adaptive immune response to various antigens.

Another noteworthy patent involves the formulation of vaccines featuring an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule. This invention targets improved responses against viral pathogens and includes a peptide of the formula R—XZSZ—XZX—R, complemented by deoxynucleic acid containing deoxyinosine and/or deoxyuridine residues.

Career Highlights

Throughout his career, Michael Buschle has collaborated with esteemed organizations, most notably Intercell AG and Boehringer Ingelheim International GmbH. His work in these companies has allowed him to push the boundaries of vaccine technology and contribute to significant advancements in public health.

Collaborations

Buschle's success can also be attributed to his collaborations with notable colleagues such as Frank Mattner and Wolfgang Zauner. Working alongside these professionals has facilitated the exchange of ideas and expertise, enhancing the innovative outcomes of their joint efforts in vaccine research.

Conclusion

Michael Buschle's inventive prowess and dedication to advancing immunology through his patents underscore his role as a key player in the field of vaccine development. His contributions not only reflect his individual talents but also the impact of collaboration in the scientific community. As vaccine technology continues to evolve, Buschle's innovations will undoubtedly play a crucial role in combating infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…